Expertise in
36
conditions

Dr. Joy Schechtman

Rheumatology
Sunvalley Arthritis Center Ltd
6818 W Thunderbird Rd, 
Peoria, AZ 
Accepting New Patients
Offers Telehealth
Expertise in
36
conditions
Sunvalley Arthritis Center Ltd
6818 W Thunderbird Rd, 
Peoria, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joy Schechtman is a Rheumatologist in Peoria, Arizona. Dr. Schechtman is highly rated in 36 conditions, according to our data. Her top areas of expertise are Rheumatoid Arthritis (RA), Osteoporosis, Bursitis, and Postmenopausal Osteoporosis. Dr. Schechtman is currently accepting new patients.

Her clinical research consists of co-authoring 4 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in AZ
Hospital Affiliations
Honor Health John C. Lincoln Medical Center
Languages Spoken
English
German
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 22 Less Insurance Carriers -

Locations

SUNVALLEY ARTHRITIS CENTER LTD
6818 W Thunderbird Rd, Peoria, AZ 85381
Other Locations
BHSM REHABILITATION LLC
5605 W Eugie Ave, Suite 212and215, Glendale, AZ 85304

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
EpiCeram for Skin Protection in Healthcare Workers Using Personal Protective Equipment
EpiCeram for Skin Protection in Healthcare Workers Using Personal Protective Equipment
Enrollment Status: Terminated
Publish Date: August 28, 2024
Intervention Type: Device
Study Phase: Not Applicable
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug, Biological
Study Drug: Zostavax Herpes Zoster Vaccine
Study Phase: Phase 2
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Enrollment Status: Completed
Publish Date: August 17, 2017
Intervention Type: Dietary supplement, Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

4 Total Publications

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study.
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study.
Journal: BMC rheumatology
Published: May 23, 2022
Similar Doctors
Expertise in
37
conditions
Dr. Ravi M. Bhalla
Rheumatology
Expertise in
37
conditions
Dr. Ravi M. Bhalla
Rheumatology

Bhsm Rehabilitation LLC

5605 W Eugie Ave, Suite 212and215, 
Glendale, AZ 
 (1.4 miles away)
602-865-5830
Languages Spoken:
English, Hindi, Punjabi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ravi Bhalla is a Rheumatologist in Glendale, Arizona. Dr. Bhalla is highly rated in 37 conditions, according to our data. His top areas of expertise are Palindromic Rheumatism, Fibromyalgia, Rheumatoid Arthritis (RA), and Postmenopausal Osteoporosis. Dr. Bhalla is currently accepting new patients.

Expertise in
17
conditions
Dr. Vivek Nagaraja
Rheumatology
Expertise in
17
conditions
Dr. Vivek Nagaraja
Rheumatology

Mayo Clinic Building SCT-1

13400 E Shea Blvd, 
Scottsdale, AZ 
 (23.7 miles away)
480-301-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vivek Nagaraja is a Rheumatologist in Scottsdale, Arizona. Dr. Nagaraja is highly rated in 17 conditions, according to our data. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Scleroma, and Scleredema. Dr. Nagaraja is currently accepting new patients.

Expertise in
35
conditions
Dr. Vijayabhanu Mahadevan
Rheumatology
Expertise in
35
conditions
Dr. Vijayabhanu Mahadevan
Rheumatology

American Arthritis And Rheumatology Associates - Az PLLC

12665 W Smokey Dr, Suite 140, 
Surprise, AZ 
 (7.5 miles away)
623-219-4040
Languages Spoken:
English, Hindi, Tamil
See accepted insurances
Offers Telehealth

Vijayabhanu Mahadevan is a Rheumatologist in Surprise, Arizona. Dr. Mahadevan is highly rated in 35 conditions, according to our data. Her top areas of expertise are Rheumatoid Arthritis (RA), Osteoporosis, Postmenopausal Osteoporosis, and Rhizomelic Pseudopolyarthritis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schechtman's expertise for a condition
ConditionClose
    View All 15 Distinguished Conditions
    View All 21 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile